EDAP TMS S.A. FOCL
Set alert
4.18 USD 0.00 0.00%
At close · Oct 30
4.27 +0.09 +2.15%
After hours · Oct 30, 4:00 PM ET
Day range unavailable
1.82 52-week range 6.40
- YTD
- +27.05%
- 1 year
- +92.63%
- Open
- —
- Prev close
- 4.18
- Mkt cap
- 197.37M
- Vol
- 0
- Avg vol
- 110.00K
- EPS
- -1.39
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
3M chart
Signals (23)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 29, 2026 | 4 days ago |
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Oct 13, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 13, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 8, 2026 | 1 month ago |
| RSI: Oversold | Aug 17, 2026 | 2 months ago |
| RSI: Oversold | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 5, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
| RSI: Overbought | Aug 4, 2026 | 3 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
Financials — quick view
FOCL Revenue — quarterly 13.20M
FOCL Net income — quarterly -14.49M
FOCL EPS — quarterly -0.39
News
- HC Wainwright & Co. Reiterates Buy on Edap TMS, Maintains $10 Price Target
- Edap TMS Q2 2026 Earnings Call: Complete Transcript
- FocalTherics Q2 EPS $(0.38) Misses $(0.20) Estimate, Sales $13.200M Miss $14.440M Estimate
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- FocalTherics Reports Preliminary Q2 Sales Of $12.7M-$13.2M, Up 34%-39% Year-On-Year
- FocalTherics Announces Underwritten Public Offering Of ADSs
- FocalTherics Launches First European Commercial Endometriosis Focal One Program With Treatment Of Initial Patients In Toulouse, France
- FocalTherics Expanding Focal One Robotic HIFU Access Under Signed Agreement With MellingMedical To Federal Healthcare Providers
- HC Wainwright & Co. Reiterates Buy on FocalTherics, Maintains $10 Price Target
Your note
Sign in to keep a note on FOCL — it syncs with the Stock Master app.